000 01405 a2200457 4500
005 20250515043234.0
264 0 _c20061030
008 200610s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/wnl.67.7_suppl_2.s18
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCaccia, C
245 0 0 _aSafinamide: from molecular targets to a new anti-Parkinson drug.
_h[electronic resource]
260 _bNeurology
_cOct 2006
300 _aS18-23 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlanine
_xanalogs & derivatives
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xchemistry
650 0 4 _aBenzylamines
_xchemistry
650 0 4 _aBrain Ischemia
650 0 4 _aDisease Models, Animal
650 0 4 _aGerbillinae
650 0 4 _aHumans
650 0 4 _aKainic Acid
_xtoxicity
650 0 4 _aLevodopa
_xtherapeutic use
650 0 4 _aMPTP Poisoning
_xdrug therapy
650 0 4 _aMice
650 0 4 _aNeurons
_xcytology
650 0 4 _aRats
650 0 4 _aVeratridine
_xtoxicity
700 1 _aMaj, R
700 1 _aCalabresi, M
700 1 _aMaestroni, S
700 1 _aFaravelli, L
700 1 _aCuratolo, L
700 1 _aSalvati, P
700 1 _aFariello, R G
773 0 _tNeurology
_gvol. 67
_gno. 7 Suppl 2
_gp. S18-23
856 4 0 _uhttps://doi.org/10.1212/wnl.67.7_suppl_2.s18
_zAvailable from publisher's website
999 _c16607346
_d16607346